Atlanta, Ga. (Aug. 13, 2007) - Implantable Provider Group (IPG) has secured $8 million in private funding to help the company expand its business. IPG, based in Alpharetta, offers solutions for healthcare providers, payors and manufacturers to alleviate the financial risk and management issues associated with implantable medical devices. Fulcrum Ventures, an Atlanta-based private equity firm, led the investment with preferred equity and sub-debt and also arranged a senior debt facility with Gemino Healthcare Finance.

Through Implantable Device ManagementSM program, IPG reduces the financial exposure that the purchase of high-cost implantable devices can bring to hospitals, ambulatory surgical centers and physicians' offices. Implantable Device Management also dramatically lowers the costs of implanted medical devices for commercial insurance plans through preferred pricing and a streamlined claims and billing process.

"We were introduced to IPG through one of our investors and immediately recognized that the Company enjoyed a leadership position in an attractive, emerging segment of health care with the potential for enormous growth" said Tom Greer, partner of Fulcrum Ventures. "We are very excited to be partnered with IPG as a portfolio company."

Fulcrum's investment will help IPG expand its business, establishing relationships with additional medical facilities and commercial payors, as well as building its corporate infrastructure and systems.

"The implantable device market is growing at a tremendous pace," said Jay Ethridge, chief executive officer of IPG. "As this growth continues and even picks up pace, there is a potential for healthcare providers and payors to be overwhelmed with management issues related to coverage benefits, billing, reimbursements, and collections associated with these devices. IPG has all of the systems and expertise to simplify the process and reduce costs, from procurement to collections. Bringing on a partner like Fulcrum Ventures positions IPG to dramatically increase our reach in the market and accelerate growth plans," he added.

Founded in 2004, IPG has been profitable and experienced triple-digit growth every year since inception. The company focuses on large, fast-growth medical implant markets, such as cardiology, neurology and orthopedic implants.